AA
GILD icon

ABC Arbitrage’s Gilead Sciences GILD Stock Holding History

ABC Arbitrage’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
2,275
+9
+0.4% +$1.19K 0.03% 242
2026
Q1 		$316K Buy
+2,266
New +$317K 0.04% 206

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ABC Arbitrage's GILD Position: Q2 2026 in Review

ABC Arbitrage increased its Gilead Sciences (GILD) stake by 0.4% in Q2 2026, buying an estimated $1.19K and bringing the position to 2,275 shares worth $287K. The position accounts for 0.03% of the portfolio, ranked #242.

ABC Arbitrage first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $316K in Q1 2026. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ABC Arbitrage held 2,275 shares of Gilead Sciences worth $287K as of Q2 2026.
  • ABC Arbitrage bought 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
  • Gilead Sciences made up 0.03% of ABC Arbitrage's portfolio in Q2 2026, its #242 holding.
  • ABC Arbitrage first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • ABC Arbitrage's Gilead Sciences position peaked at $316K in Q1 2026.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.